CompoAtlas

Hepatiben

Natural health product licensed in Canada

Licence holder
Liver Medic INC
NPN or DIN-HM
80105134
Status
Active licence
Licence date
13 October 2020
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Phosphatidylcholine

Source : Glycine max - Graine

75 mgNot calculated
Acide DL-alpha-lipoïque

Source : Acide DL-alpha-lipoÏque

25 mgNot calculated
Chlorure de 5,6-dihydro-9,10-diméthoxybenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium

Source : Berberine hydrochloride

25 mgNot calculated

Non-medicinal ingredients

farine de riz, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule4 Tous les jours

Uses authorised in Canada

Milk Thistle is traditionally used in Herbal Medicine as a hepatoprotectant/ liver protectant. (Used in Herbal Medicine to) help(s) to support liver function. Used in Herbal Medicine to help relieve digestive disturbances/dyspepsia. Source of/Provides antioxidants. Provides antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80105134

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line